The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Cannabinoid Receptor Activation Differentially Regulates the Various Adenylyl Cyclase Isozymes
Abstract
Two cannabinoid receptors belonging to the superfamily of G protein-coupled membrane receptors have been identified and cloned: the neuronal cannabinoid receptor (CB1) and the peripheral cannabinoid receptor (CB2). They have been shown to couple directly to the G(i/o) subclass of G proteins and to mediate inhibition of adenylyl cyclase upon binding of a cannabinoid agonist. In several cases, however, cannabinoids have been reported to stimulate adenylyl cyclase activity, although the mechanism by which they did so was unclear. With the cloning of nine adenylyl cyclase isozymes with various properties, including different sensitivities to alpha(s), alpha(i/o), and betagamma subunits, it became important to assess the signaling pattern mediated by each cannabinoid receptor via the different adenylyl cyclase isozymes. In this work, we present the results of cotransfection experiments between the two types of cannabinoid receptors and the nine adenylyl cyclase isoforms. We found that independently of the method used to stimulate specific adenylyl cyclase isozymes (e.g., ionomycin, forskolin, constitutively active alpha(s), thyroid-stimulating hormone receptor activation), activation of the cannabinoid receptors CB1 and CB2 inhibited the activity of adenylyl cyclase types I, V, VI, and VIII, whereas types II, IV, and VII were stimulated by cannabinoid receptor activation. The inhibition of adenylyl cyclase type III by cannabinoids was observed only when forskolin was used as stimulant. The activity of adenylyl cyclase type IX was inhibited only marginally by cannabinoids.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Stimulation of CB1R recruits various signaling pathways [22]. These pathways include CB1R coupling to Gi/o proteins that reduces adenylyl cyclase activity and downregulates cyclic AMP/protein kinase A signaling [23], by Gβγ-induced phospholipase C-β-mediated increases in intracellular calcium influx, and by activation of mitogen-activated protein kinases [24,25].”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [24]
Citations
Cites
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Galiègue, S., Mary, S., Marchand, J., Dussossoy, D., Carrière, D., Carayon, P., Bouaboula, M., Shire, D. J., Fur, G. L., & Casellas, P. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20780.x · Cited by 1,776
Receptor-effector coupling by G proteins
Birnbaumer, L., Abramowitz, J., & Brown, A. M. (1990) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(90)90007-y · Cited by 1,118
Complexity and Diversity of Mammalian Adenylyl Cyclases
Sunahara, R. K., Dessauer, C. W., & Gilman, A. G. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.002333 · Cited by 874
Voltage-dependent modulation of N-type calcium channels by G-protein β γsubunits
Ikeda, S. R. (1996) · Nature · doi:10.1038/380255a0 · Cited by 827
Ras-dependent activation of MAP kinase pathway mediated by G-protein βγ subunits
Crespo, P., Xu, N., Simonds, W. F., & Gutkind, J. S. (1994) · Nature · doi:10.1038/369418a0 · Cited by 801
Adenylyl Cyclase Amino Acid Sequence: Possible Channel- or Transporter-Like Structure
Krupinski, J., Coussen, F., Bakalyar, H. A., Tang, W., Feinstein, P. G., Orth, K., Slaughter, C. A., Reed, R. R., & Gilman, A. G. (1989) · Science · doi:10.1126/science.2472670 · Cited by 738
Mammalian Membrane-bound Adenylyl Cyclases
Taussig, R., & Gilman, A. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.1.1 · Cited by 719
SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor
Rinaldi, M. L., Barth, F., Millan, J., Derocq, J., Casellas, P., Congy, C., Oustric, D., Sarran, M., Bouaboula, M., Calandra, B., et al. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37266-0 · Cited by 716
Cited by
Sorted by citations
Items 101–160 of 160
Mechanism of isoproterenol-induced RGS2 up-regulation in astrocytes
Kim, S., Lee, W. M., Suk, K., Park, S., Kim, S. K., Cho, J. Y., & Rhee, M. H. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.08.061 · Cited by 9
Silva-Llanes, I., Rodríguez-López, S., González-Naranjo, P., del Sastre, E., López, M. G., Paez, J. A., Campillo, N. E., & Lastres‐Becker, I. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.03.008 · Cited by 8
Neuroprotective activity of new Δ3‐N ‐acylethanolamines in a focal ischemia stroke model
Shirazi, R. S., Vyssotski, M. V., Lagutin, K., Thompson, D. R., Macdonald, C. E., Luscombe, V. B., Glass, M., Parker, K., Gowing, E. K., Williams, D. B. G., et al. (2021) · Lipids · doi:10.1002/lipd.12326 · Cited by 7
Alqarni, M. H., Myint, K. Z., Tong, Q., Yang, P., Bartlow, P., Wang, L., Feng, R., & Xie, X. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.08.048 · Cited by 8
Anandamide-Mediated Modulation of Nociceptive Transmission at the Spinal Cord Level
Spicarova, D., & Paleček, J. (2024) · Physiological Research · doi:10.33549/physiolres.935371 · Cited by 7
Cannabinoids and GI Disorders: Endogenous and Exogenous
Reichenbach, Z. W., & Schey, R. (2016) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-016-0111-1 · Cited by 7
Basavarajappa, B. S., Yalamanchili, R., Cooper, T. B., & Hungund, B. L. (2008) · Springer eBooks · doi:10.1007/978-0-387-30382-6_14 · Cited by 7
Evidence-based Potential Therapeutic Applications of Cannabinoids in Wound Management
Kibret, B. G., Patel, S. A., Niezgoda, J., Guns, W. M., Niezgoda, J., Gopalakrishnan, S., Baban, B., Cubillos, P., Villeneuve, D. M., & Kumar, P. (2022) · Advances in Skin & Wound Care · doi:10.1097/01.asw.0000831920.15801.25 · Cited by 6
Can cannabidiol have an analgesic effect?
Kulesza, B., Mazurek, M., & Kurzepa, J. (2023) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12947 · Cited by 6
Endothelial TRP channels and cannabinoid receptors are involved in affinin-induced vasodilation
Valencia-Guzmán, C. J., CASTRO-RUÍZ, J. E., García-Gasca, T., Rojas‐Molina, A., Romo‐Mancillas, A., Vázquez, F. J. L., Rojas-Molina, J., & Ibarra‐Alvarado, C. (2021) · Fitoterapia · doi:10.1016/j.fitote.2021.104985 · Cited by 7
Vallano, M. L., Beaman‐Hall, C. M., Bui, C. J., & Middleton, F. A. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.11.012 · Cited by 6
The use of cannabinoids in multiple sclerosis
Teare, L., & Zajicek, J. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.7.859 · Cited by 6
Endocannabinoids and Their Synthetic Analogs
Vemuri, K. V., & Makriyannis, A. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-503-9_2 · Cited by 6
A ZINDO/1 STUDY OF THE CANNABINOID-MEDIATED INHIBITION OF ADENYLYL CYCLASE
mez-Jeria, J. S. G., Morales, F., & Gutiérrez, G. (2003) · Cited by 5
Mecanismos moleculares de la adicción a la marihuana
Toledo, I. E. E., Mejía, M. C. B., & Ramírez, D. M. G. (2009) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 5
Gonçalves, Y. C., Campos, K. C. D. F., Vasconcelos, E. D. S., Eça, B. M. D., Rantin, F. T., Kalinin, A. L., & Monteiro, D. A. (2023) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2023.109822 · Cited by 4
CB2 receptor as a potential target in age-related diseases
Kauppinen, A., Nevalainen, T., Hytti, M., Salminen, A., & Parkkari, T. (2014) · Cited by 4
The role of the type 7 adenylyl cyclase isoform in alcohol use disorder and depression
Tabakoff, B., & Hoffman, P. L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1012013 · Cited by 4
Cannabinoid Receptors and Their Signaling Mechanisms
Basavarajappa, B. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809666-6.00002-2 · Cited by 4
Pharmacology of Endocannabinoids and Their Receptors
Gupta, G., Hourani, W., Deb, P. K., Deka, S., Borah, P., Tiwari, J., Pathak, S., & Kumar, P. (2020) · Springer eBooks · doi:10.1007/978-981-15-3556-7_13 · Cited by 4
Cannabinoid receptors in GtoPdb v.2023.1
Abood, M. E., Alexander, S. P. H., Barth, F., Bonner, T. I., Bradshaw, H. B., Cabral, G. A., Casellas, P., Cravatt, B. F., Devane, W. A., Marzo, V. D., et al. (2023) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f13/2023.1 · Cited by 3
Endocannabinoids and Intracellular Signaling
McAllister, S. D., & Abood, M. E. (2005) · CRC Press eBooks · doi:10.1201/9781420023640.ch4 · Cited by 3
Sánchez, M., & Miquel (2003) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 3
Functional Selectivity at Receptors for Cannabinoids and Other Lipids
Howlett, A. C. (2009) · The Receptors · doi:10.1007/978-1-60327-335-0_11 · Cited by 2
Atance, J. A. R., & Fernández‐Ruíz, J. (2000) · Adicciones · doi:10.20882/adicciones.672 · Cited by 2
Хаспеков, Л. Г., & Bobrov, М. Y. (2007) · Neurochemical Journal · doi:10.1134/s1819712407020018 · Cited by 2
Reggio, P. H. (2005) · CRC Press eBooks · doi:10.1201/9781420023640.ch2 · Cited by 2
Physiological roles of fatty acids and endocannabinoids in the nematode Caenorhabditis elegans
Reisner, K. (2012) · UEF eRepo (University of Eastern Finland) · Cited by 2
Kim, S.-D. L. (2009) · Journal of Life Science · doi:10.5352/jls.2009.19.11.1506 · Cited by 1
Cannabinoids in Opioid Addiction Treatment: Pharmacological Mechanisms
Zuo, Q., Tam, K. L., Bekker, A., Zuo, W., & Ye, J.-H. (2019) · doi:10.35248/2329-6488.19.7.325 · Cited by 1
DEVELOPMENT OF CANNABINOID SUBTYPE-1 (CB1) RECEPTOR LIGANDS FOR PET
Donohue, S. R. (2008) · Figshare · Cited by 1
Borgkvist, A. (2008) · Figshare
Makwana, R. (2007) · University of Hertfordshire Research Archive (University of Hertfordshire)
Effects of Cannabinoid Receptor Interacting Protein (CRIP1a) on Cannabinoid Receptor (CB1) Function
Smith, T. H. (2009) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/0fn5-w762
Blume, L. C., Eldeeb, K., & Howlett, A. C. (2014) · doi:10.1002/9781118451281.ch2
Synaptic action of anandamide and related substances in mammalian brain
Liao, C. Y. (2007) · Summit (Simon Fraser University)
Piechowski, C. L. (2014) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-6289
Assini, F. L. (2011) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Zhou, H. (2014) · Digital Repository Service (Northeastern University) · doi:10.17760/d20004824
CB1 Receptor-Mediated Signaling Mechanisms in the Deleterious Effects of Spice Abuse
Basavarajappa, B. S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800213-1.00071-7
DESIGN, EXPRESSION AND PURIFICATION OF FUNCTIONAL HUMAN CANNABINOID RECEPTOR 2
Alqarni, M. A. (2016) · D-Scholarship@Pitt (University of Pittsburgh)
Bioactivity of Medicinal Plants: Progress and Perspectives
Ríos, P. J.-L., & Sendra, R. A. (2009)
Cannabimimetics: The Pharmacological Potential of Cannabinoid Receptor Ligands
Gertsch, J. (2009) · Science Publishers eBooks
Suarez-Martinez, J. E. (2016) · Michigan State University Libraries · doi:10.25335/m5pt9z
ENDOCANNABINOID REGULATION OF ADOLESCENT DEVELOPMENT IN MALE AND FEMALE RATS
Simone, J. J. (2018) · Brock University Digital Repository (Brock University)
Alghamdi, S. S. (2020) · doi:10.21007/etd.cghs.2019.0492
Gertsch, J. (2009) · Science Publishers eBooks · doi:10.1201/b10200-12
Bodke, S., & Bhatt, L. K. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02120-w
Cross-talk between melatonin type 1 and cannabinoid type 1 receptors
Cui, Y. (2022) · theses.fr (ABES) · doi:10.70675/3dab490dz44d1z43a6za1e7zf7daf8357d93
Insight into the mode of action of phytocannabinoids against ovarian cancer and glioblastoma
Koltai, H., & Kendall, B. E. (2026) · Phytomedicine Plus · doi:10.1016/j.phyplu.2026.101012
Metadata
- Authors
- Rhee, M., Bayewitch, M., Avidor‐Reiss, T., Levy, R., & Vogel, Z.
- Affiliations
- Weizmann Institute of Science (IL)
- Corresponding author
- Vogel, Zvi
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 1998-10
- Volume
- 71
- Issue
- 4
- Pages
- 1525-1534
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2035086154
- Cited by
- 159
- References
- 56
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 3 · 2023: 5 · 2022: 6 · 2021: 6 · 2020: 8 · 2019: 7 · 2018: 5 · 2017: 6 · 2016: 7 · 2015: 3 · 2014: 10 · 2013: 4 · 2012: 1
- FWCI
- 3.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Neurochemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01da006265-09)
- National Institute on Drug Abuse (DA 06265)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- cannabinoid receptors, CB1 receptor, CB2 receptor, G protein-coupled receptors, G protein signaling, adenylate cyclase inhibition, forskolin, beta gamma subunits, thyroid-stimulating hormone receptor, cotransfection
- MeSH terms
- Adenylyl Cyclase Inhibitors, Adenylyl Cyclases, Animals, Cannabinoids, Enzyme Activation, Humans, Isoenzymes, Morpholines, Naphthalenes, Receptors, Drug, Dronabinol, Transfection, COS Cells, Receptors, Cannabinoid, Receptor, Cannabinoid, CB2, Benzoxazines, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review